TRP Channels are a group of ion channels that are primarily found on the plasma membrane of various types of human and animal cells. There are about 28 TRP channels, and many of them are structurally related to one another. These are divided into two major categories: TRPC ("C" for canonical), TRPV ("V" for vanilloid), TRPM ("M" for melastatin), TRPN, and TRPA are all members of Group 1. There are two members of group 2: TRPP (for polycystic) and TRPML (for mucolipin). A large number of these channels mediate a wide range of sensations, including pain, hotness, warmth, or coldness, various tastes, pressure, and vision. Cations like sodium, calcium, and magnesium are relatively non-selectively permeable to TRP channels. The fruit fly Drosophila trp-mutant strain is where TRP channels were first identified. TRP channels are later discovered in vertebrates, where they are widely expressed in a variety of cell types and tissues. TRP channels are crucial for human health because at least four diseases are caused by mutations in these channels.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V117549 | FP802 | 61694-81-3 | FP802 is an orally effective and potent TwinF interface inhibitor that can disrupt and neutralize the toxicity of the NMDAR/TRPM4 death complex. |
|
V114795 | FP802 dihydrochloride | 2490401-57-3 | FP802 hydrochloride is an orally effective and potent TwinF interface inhibitor that can disrupt and neutralize the toxicity of the NMDAR/TRPM4 death complex. |
|
V70135 | GDC-0334 | 1984824-54-5 | GDC-0334 is a TRPA1 selective antagonist. |
|
V70128 | GDC-6599 | 2376824-99-4 | GDC-6599 (Example 8) is an orally bioavailable TRPA1 inhibitor. |
|
V40197 | GFB-8438 | 2304549-73-1 | GFB-8438 is a novel, highly potent and subtype specific TRPC5 inhibitor with IC50s of 0.18 and 0.29 μM of hTRPC5 and hTRPC4, respectively. |
|
V136725 | Glucoputranjivin | 18432-16-1 | Glucoputranjivin is a reference compound that can be used for the qualitative and quantitative determination of active compounds in SO₂. |
|
V3576 | GSK1016790A | 942206-85-1 | GSK1016790A is a novel and potent transient receptor potential vanilloid 4 (TRPV4) activator. |
|
V3556 | GSK2193874 | 1336960-13-4 | GSK2193874 (GSK-2193874) is a novel, potent, orally bioactive, and selectiveTRPV4 (Transient Receptor Potential Vanilloid 4)antagonist with the potential to be used forcongestive heart failure. |
|
V136953 | GSK2220691 | 1206619-37-5 | GSK2220691 is a potent TRPV4 inhibitor. |
|
V136963 | GSK3527497 | 2215855-22-2 | GSK3527497 is an orally effective TRPV4 inhibitor. |
|
V107521 | HC-067047 hydrochloride | 1481646-76-7 | HC-067047 hydrochloride is a potent and selective TRPV4 antagonist that reversibly inhibits currents of human, rat, and mouse TRPV4 homologues with IC50 values of 48 nM, 133 nM, and 17 nM, respectively. |
|
V22085 | HC-070 | 1628291-95-1 | HC-070 is a novel and potent inhibitor of TRPC4 and TRPC5 with IC50s of 9.3 nM and 46 nM for hTRPC5 and hTRPC4 in cell assay. |
|
V87245 | hTRPA1-IN-1 | hTRPA1-IN-1 (19), a sesquiterpenoid isolated from the sea sponge Diacarnus spinipoculum, is an inhibitor of transient receptor potential cation channel phalloidin 1 (TRPA1) with an IC50 of 2 μM. | |
|
V70130 | Hyp9 | 3118-34-1 | Hyp9 is a transient receptor potential cation channel 6 (TRPC6) specific agonist. |
|
V137733 | HZS60 | 3027529-88-7 | HZS60 is a brain-penetrating NMDAR/TRPM4 inhibitor that can improve cerebral ischemia. |
|
V2999 | Icilin | 36945-98-9 | Icilin (also known as AG-3-5 or AG 3-5) is a synthetic CMR1/TRPM8 (transient receptor potential M8) super-cooling agent/agonist that is 2.5-fold more efficacious and nearly 200-fold more potent than the reference cold thermosensory agonist, l-menthol. |
|
V70155 | JNJ-28583113 | 2765255-93-2 | JNJ-28583113 is a brain-permeable (penetrable) TRPM2 antagonist. |
|
V116031 | JNJ-38893777 | 951135-00-5 | JNJ-38893777 is an orally effective, highly selective transient receptor potential capsaicin type 1 (TRPV1) channel antagonist. |
|
V94847 | JW-65 | 2763378-71-6 | JW-65 (Compound 20) is a TRPC3 inhibitor. |
|
V111545 | JYL-273 analog-1 | 289902-71-2 | JYL-273 analog-1 (compound 28, Example 45) is a potent transient receptor potential ion channel (TRP channel) (TRPV1) agonist (Ki = 10.8 nM). |